Instructive programs guiding cell fate decisions in the developing mouse embryo are controlled by a few so-termed master regulators. Genetic studies demonstrate that the T-box transcription factor Eomesodermin (Eomes) is essential for epithelial to mesenchymal transition (EMT), mesoderm migration and specification of definitive endoderm (DE) during gastrulation 1 . Here we report that Eomes expression within the primitive streak marks the earliest cardiac mesoderm and promotes formation of cardiovascular progenitors by directly activating the bHLH transcription factor Mesp1 upstream of the core cardiac transcriptional machinery [2] [3] [4] . In marked contrast to Eomes/ Nodal signalling interactions that cooperatively regulate anterior-posterior (A-P) axis patterning and allocation of the DE cell lineage 1, 5-8 , formation of cardiac progenitors requires only low levels of Nodal activity accomplished via a Foxh1/Smad4 independent mechanism. Collectively our experiments demonstrate that Eomes governs discrete context dependent transcriptional programmes that sequentially specify cardiac and DE progenitors during gastrulation.
mesoderm arises from the posterior PS, while cardiac, paraxial and lateral plate precursors emerge sequentially as the PS elongates towards the distal tip of the embryo. Fate mapping experiments demonstrate that DE progenitors are specified in the most anterior region of the PS (APS), in close proximity to the cardiovascular progenitors 10, 11 .
Mesoderm formation and patterning along the proximodistal axis of the PS is known to be regulated by dose-dependent Nodal/Smad2/3 activities 7 . The highest level of Nodal/Smad2/3 signaling is required to specify APS derivatives, namely the DE, node and notochord 5, 6, 8 . The transcription factor Smad4, and its DNA-binding partner the forkhead transcription factor Foxh1, also play essential roles in APS specification 6, 12, 13 . Additionally, the T-box transcription factor Eomes acts cooperatively with the Nodal/Smad2/3 pathway to promote delamination of nascent mesoderm and specification of APS fates 1 .
Eomes expression is initiated in the prospective posterior aspect of the epiblast at embryonic day 5.75 (E5.75) 14 . During gastrulation expression is maintained in the distal PS 14, 15 , encompassing the same region where cranial, cardiac and paraxial mesodermal sub-cell populations are generated 10 . Inactivation of Eomes in the epiblast results in a severe block in EMT and arrests development at gastrulation 1 . To further characterise Eomes functional contributions within the mesodermal cell lineages we generated an Eomes Cre reporter allele. Cre mRNA expression recapitulates endogenous expression (Supplementary Information, Fig. S1a ) allowing derivation of a fate map of Eomes expressing cells in later stage embryos (Fig. 1) . Eomes Cre/+ males were mated to females carrying the ROSA26 R reporter strain 16 and the resulting embryos stained for LacZ activity (Fig. 1d , e, Supplementary Information, Fig. S1b) . Surprisingly, we found in E8.5 and E 9.5 Eomes Cre ; ROSA26 R embryos that LacZ expressing cells are mostly absent from the somites, intermediate and lateral plate mesoderm and largely restricted to the head mesenchyme, cardiac mesoderm and vasculature (Fig. 1d , e). As expected 1 , the DE and gut tube are exclusively comprised of LacZ marked Eomes Cre + descendants. At later stages endodermal but not mesodermal components of developing organs derived from the gut tube are LacZ positive ( Supplementary Information,  Fig. S1c ). Eomes expressing cells thus give rise to two discrete progenitor cell populations during gastrulation, namely the prospective cranial and cardiac mesoderm that emerge from the PS at early stages, and APS derivatives giving rise to the DE, node and notochord. In striking contrast Eomes+ cells are excluded from the majority of mesodermal tissues derived from the paraxial and lateral plate mesoderm. These observations strongly suggest that a discrete sub-population of cells within the pre-gastrulation epiblast preferentially ingress and migrate anteriorly as a cohort to form the cardiac crescent and prospective head mesoderm.
To directly examine whether Eomes function is required for specification of cardiovascular progenitors we analysed E7.5 embryos carrying an epiblast-specific Eomes deletion (Eomes CA/N ;Sox2.Cre) 1 by whole mount in-situ hybridization (WISH). Embryos lacking Eomes function strongly express mesodermal marker genes, including Brachyury, Fgf8 and Snail 1 . However in striking contrast expression of early cardiac marker genes, Myl7 (also known as Mlc2a), Wnt2 and Nkx2.5 was absent (Fig. 2a) . Moreover we observe severely reduced expression of early vascular marker genes such as Agtrl1, Rasgrp3 and Klhl6 (Fig.  2a) .
To test whether loss of cardiac gene expression reflects a cell autonomous Eomes requirement we examined the developmental potential of Eomes null embryonic stem (ES) cells in the context of chimeric embryos. Eomes null ES cells 1 were injected into wild type blastocysts carrying the ROSA26 LacZ allele 17 and the resulting embryos analysed by X-Gal staining (Fig. 2b) . As expected 1 at E8.5 and E9.5 Eomes null cells efficiently contribute to the majority of mesodermal tissues but are entirely excluded from the forming gut tube. Strikingly in all cases examined (n=10), the myocardium and endocardium of the developing heart were also exclusively comprised of wild type LacZ+ cells (Fig. 2c, d ). Thus we conclude that Eomes plays an essential cell autonomous role during allocation of both the DE and cardiovascular progenitors.
To further evaluate Eomes contributions we exploited culture protocols that promote ES cell differentiation towards either DE or cardiac fates. To elicit DE formation, ES cells harboring an Eomes GFP reporter allele 18 were cultured in the presence of high doses of ActivinA (50ng/ml, Supplementary Information, Fig. S2a ). After 4 days, as judged by GFP expression or staining with an Eomes antibody, >95% of cells were strongly positive ( Supplementary  Information, Fig. S2b , and data not shown). Next we compared wild type (CCE), Eomes null (6A6) 1 and Smad2 null (KT15) 7 ES cells and monitored DE marker gene expression by RT-PCR. Eomes expression was detectable 24hrs after ActivinA treatment in wild type cells, severely reduced in Smad2-deficient cells and absent in Eomes null cells (Fig. 3a) . In chimera studies Smad2-deficient cells robustly contribute to all mesodermal lineages but are excluded from DE derivatives 19 and as shown here only inefficiently up-regulate expression of Eomes or DE markers.
Differentiating Eomes null ES cells strongly express PS and mesodermal marker genes, including Brachyury and Mixl1 but expression of DE marker genes including Sox17 and Foxa2 was drastically reduced. Similar conclusions were reached in Q-RT-PCR experiments examining a panel of key DE-associated genes including Gsc, Gata6 and Lhx1 (Fig. 3b) .
Next we examined the development of cardiac progenitors via embryoid body (EB) differentiation in hanging drops with high serum-stimulation 20 ( Supplementary Information,  Fig. S2c, d ). In wild type cultures Eomes transcripts are detectable by RT-PCR on day 2, peak around day 4 and are down-regulated by day 6 (Fig. 3c) . Coincident with highest levels of Eomes expression, early cardiac markers Mesp1 and Myl7 are upregulated beginning at around day 4. In Eomes null EBs the pan-mesodermal marker Brachyury is robustly induced (Fig.3c ), but in marked contrast expression of cardiac-specific genes including Mesp1, Myl7 Myl2, Myocardin, Nkx2.5 and Mef2c was entirely absent. As judged by microscopic observation and staining for the cardiac protein TroponinI (TnI), close to 100% of wild type EBs contain clusters of contractile cardiomyocytes after day 7 of differentiation ( Fig. 3d , e, Supplementary Information, Movie SM1). Eomes null EBs fail to differentiate into cardiomyocytes by these criteria (Fig. 3d , e, Supplementary Information, Movie SM2). Collectively these results suggest that Eomes acts upstream of the transcriptional hierarchy that specifies cardiac fates during gastrulation.
The bHLH transcription factor Mesp1 has been described a master regulator of multipotent cardiovascular progenitor specification [21] [22] [23] . Genetic fate mapping experiments demonstrate that Mesp1 expression marks cardiac progenitors that give rise to the myocardial and endocardial derivatives 22 . Moreover Mesp1 activity has also been implicated in the early steps of cardiac lineage specification in vitro [2] [3] [4] . Mesp1 is strongly expressed at the onset of gastrulation (E6.5) along the forming PS, marking the prospective cardiac mesoderm and is then rapidly down-regulated starting around E7.5 22 . Mesp1 mutants form cardiac mesoderm but heart morphogenesis is highly compromised leading to cardia bifida 21, 22 . Mesp1 and Mesp2 are functionally interchangeable in vivo 21 . Thus premature up-regulated expression of the closely related family member Mesp2 in the loss of function mutants is sufficient to generate cardiac progenitors and partially rescue heart morphogenesis 23 . Mesp1; Mesp2 double mutant embryos block at gastrulation, and display an EMT phenotype that closely resembles the Eomes loss of function phenotype 1, 23 . At E7.0 Mesp1 is completely absent in Eomes mutants (Fig. 4a) . At slightly later stages (E7.25) a few exceptional Eomes mutants display weak Mesp1 staining. At E7.25 Mesp2 expression is undetectable in WISH experiments 24 . However Q-RT-PCR analysis demonstrates that Mesp1 and Mesp2 expression are both dramatically down-regulated (Fig. 4b ). As shown above differentiating Eomes null ES cells lack the ability to upregulate Mesp1 and Mesp2 (Fig. 3c ). Collectively these experiments strongly suggest that Eomes acts upstream of Mesp1/2 to regulate EMT and control allocation of cardiac progenitors.
Mesp1 and Mesp2 are closely linked on chromosome 7, and arranged in opposite orientation with the two transcriptional start (TS) sites separated by approximately 17 kb 25 . The cisacting regulatory elements responsible for controlling temporally and spatially restricted expression patterns are well characterized [25] [26] [27] . An evolutionary conserved early mesoderm enhancer (EME, 25 , while regulatory sequences adjacent to the Mesp2 TS site direct mesodermal expression in the PS, presomitic mesoderm and developing somites 26 . Both elements contain T-box consensus binding sites [25] [26] [27] ( Supplementary  Information, Fig. S3 ). Additionally we have identified a further conserved T-box binding element in close proximity to the Mesp1 TS site ( To further investigate Mesp1/2 activation during cardiovascular lineage commitment, we used the P19Cl6 embryonal carcinoma (EC) cell line that efficiently differentiates into beating cardiomyocytes in the presence of 1% DMSO 28 . Transient Eomes expression seen initially at day 2 is down regulated by day 6, associated with increased Mesp1 expression levels (Supplementary information, Fig. S4a ). Activation of Eomes estrogen-receptor fusion protein in the presence of tamoxifen (EomesER, Supplementary Information, Fig. S4b ) also efficiently induces strong Mesp1 expression within 24 hours as assayed by Q-PCR ( Supplementary Information, Fig. S4g ). To directly evaluate Eomes occupancy at the Mesp1/2 locus we performed chromatin immunoprecipitation (ChIP) analysis with day 4 DMSO-treated P19Cl6 cells as well as tamoxifen-treated P19Cl6EomesER (P19EoER) cells. Eomes binding to all three conserved T-box site-containing regions within the Mesp1/2 locus was clearly observed (Fig. 4d, e, Supplementary Information, Fig. S5 ). The EME, which controls early Mesp1 expression in nascent mesoderm 25 gave the strongest signal. Occupancy at other genomic regions, or in uninduced cells was undetectable. The T-box sites adjacent to the Mesp2 TS site are known to be occupied by Tbx6 in pre-somitic mesoderm 27 . This cis-acting regulatory element, as well as the minimal 220 bp Mesp1 EME T-box element, regulates Mesp2 and Mesp1 expression respectively at later stages during somitogenesis 26 . Additional T-box family members are also known to be expressed in the early gastrulation stage embryo 14, 15, [29] [30] [31] . However only Brachyury and Eomes are exclusively present in the posterior epiblast and nascent mesoderm overlapping with sites of Mesp1 expression. Specification of early heart progenitors proceeds normally in T mutant embryos. Therefore a strong argument can be made that the earliest Mesp1 expression domain marking the cardiac progenitors is directly activated by Eomes occupancy at these T-box sites.
Genetic studies analyzing double heterozygous mutant embryos demonstrate that Eomes and Nodal function cooperatively in A-P axis patterning and formation of APS derivatives 1 . We wondered whether dose-dependent Nodal signals could potentially regulate Eomesdependent Mesp1 activation. To test this possibility first we examined Smad4 6 and Foxh1 mutant embryos 12 at E6.5 and E7.5. Interestingly Mesp1 expression is unaffected by loss of either Smad4 or Foxh1 (Fig. 5a ). The lim-homeodomain transcription factor Lhx1 is also required for specification of DE and anterior axial midline tissues 32, 33 . Similarly we observe that compromised DE development has no noticeable impact on specification of Mesp1+ cardiac progenitors. Thus Lhx1 loss of function embryos display strong expression of both Mesp1 and Eomes (Fig. 5a and data not shown). Conversely it is known that expression of the APS markers Lhx1 and Gsc is unperturbed in Mesp1/2 double mutant embryos 23 . Lowering Nodal 5, 34 or Smad2/3 7 levels during gastrulation also selectively disturbs DE specification. Next, we manipulated ActivinA concentrations in differentiating ES cells and confirmed that low levels (5ng/ml) are sufficient for robust Mesp1 expression, while conversely maintaining cultures in high ActivinA concentrations (50ng/ml) leads to induction of Sox17 ( Supplementary Information, Fig. S6a, b) . Collectively, these results strongly suggest that specification of both cardiac and DE progenitors requires Eomes, but these lineages arise independently, dependent on local Nodal/Smad/Foxh1 signalling levels.
Multipotent mesodermal progenitor cells that give rise to diverse tissues of the emerging body plan become progressively allocated as epiblast cells transit the PS. Fate mapping and grafting studies have shown cranial and cardiac mesoderm derive from the earliest wave of cells that exit at the mid streak stage, whereas pre-somitic/paraxial and lateral plate mesoderm emerge at more posterior levels at late streak stages 10, 11 . Remarkably the present experiments identify a sub-set of proximal posterior epiblast cells already committed to adopt a cardiac fate many hours prior to mesoderm induction and overt PS formation. The early Eomes expression domain marks cardiac progenitors programmed to activate Mesp1, previously identified as the master regulator that acts instructively to specify cardiovascular cell fates. Recent studies demonstrate that Mesp1 initiates global changes in gene expression by directly binding to regulatory sequences at the promoters of many key genes in the core cardiac transcriptional machinery. Mesp1 upregulates expression of Hand2, Myocardin, Nxk2.5 and Gata4, and represses genes governing pluripotency and mesodermal and endodermal cell fates 2 . Additionally Mesp1 promotes EMT via selective up-regulation of the zinc-finger repressor Snail 4 , allowing the nascent cardiac progenitors to migrate anteriorly to underlie the developing headfolds where they coalesce to form the cardiac crescent. Acting a few hours later during PS elongation Eomes/Nodal signalling results in specification of DE 1 that gives rise to the entire gut endoderm lineage. Eomes was recently shown to be a key player in the transcriptional network upstream of DE specification during human ES cell differentiation 35 .
How does a single transcription factor Eomes govern allocation of two independent, nonoverlapping, multipotent progenitor cell populations as epiblast cells sequentially transit the PS? We suggest that the key parameter controlling cardiac versus DE cell fate is the timing and duration of exposure to Nodal signaling (Fig. 5b) . Low levels of Nodal activity in the posterior epiblast are sufficient to activate Eomes and induce cardiac mesoderm formation at early post-implantation stages ( Supplementary Information, Fig. S6d ). Eomes expression is necessary and sufficient to activate Mesp1/2, promote EMT and migration of a discrete mesodermal sub-population that gives rise to the cardiac crescent. Within this early sub-set Mesp1 directly represses genes required for formation of DE including Foxa2, Gsc and Sox17 2 . Mesp1/2 expression also activates expression of the Nodal antagonist Lefty2 23 to further insulate cardiac progenitors as they migrate away from the source of Nodal signaling ( Supplementary Information, Fig. S6e ). Consistent with this idea, up-regulated Nodal signalling in Tgif1/2 double mutant embryos inhibits Mesp1 expression, whereas decreased levels of Nodal activity rescues Mesp1 expression 36 .
Eomes activation of Mesp1/2 in cardiac progenitors is only transient due to a Mesp1/2 autoregulatory negative feedback loop 2, 23, 25 . At late streak stages expression of Mesp1/2 is re-activated in pre-somitic mesoderm by Tbx6 occupancy of the conserved T-box sites 27 ( Fig. 5c) . In contrast during streak elongation Eomes expression is maintained by high levels of Nodal/Smad2 signaling downstream of a Wnt3/Lef1 feed-forward loop 8 . Acting together with Nodal-dependent Smad2/3/4/Foxh1 transcription complexes 5-7, 12, 34 , Eomes promotes formation of APS progenitors that give rise to the DE, node and notochord. It will be interesting to learn more about developmental regulation of Eomes transcriptional partnerships and cell type specific changes in chromatin architecture governing T-box site occupancy at the Mesp1/2 locus and selection of target genes in the DE cell lineage.
Methods

Generation of the Eomes Cre reporter allele
The Eomes Cre allele was generated using the same strategy as previously described for the EGFP knock-in allele 18 . The targeting vector encompasses a 8.25 kb HpaI fragment of the Eomes locus. Cre coding sequences were introduced into the Exon1 start site followed by a LoxP-flanked neomycin resistance cassette between the SphI (translational start) and EagI sites, resulting in removal of ~500 bp of the endogenous 5′ coding region. The 3′ homology arm was flanked by a pMC1.TK negative selection cassette. Linearised targeting vector was electroporated into CCE ES cells and drug resistant ES cell colonies screened by Southern blot using a 3′ external probe on EcoRV digested DNA (wt allele; 15.2 kb; targeted allele; 8.0 kb). Correctly targeted clones were transfected with pMC1.Cre and resulting subclones screened by Southern blot to detect the reporter allele (6.2 kb). Two independent excised cell clones were used to generate germline chimeras. Offspring were genotyped by PCR using Cre specific primers (Cre-fw: 5′-GCATAACCAGTGAAACAGCATTGCTG-3′, Crerev: 5′-GGACATGTTCAGGGATCGCCAGGCG-3′). The strain was maintained on a 129SvEv/C57Bl/6 mixed genetic background.
Mouse strains, genotyping and generation of chimeric embryos
All animal procedures were approved by the Ethical Review Committee of the University of Oxford. The ROSA26 R reporter 16 , ROSA26 gene-trap 17 , Foxh1 12 , Smad4 CA 6 , Eomes CA/N ;Sox2.Cre 1 and Lhx1 32 strains were genotyped as previously described. For generation of chimeric embryos blastocysts recovered from matings of ROSA26 males to CD1 outbred females were injected with 12-14 Eomes null ES cells 1 and transferred into E2.5 pseudopregnant foster females.
Whole-mount in situ hybridisation, LacZ staining and histology
Whole-mount in situ hybridisation analysis of E6.5-9.5 embryos dissected and fixed with 4% PFA overnight at 4 °C was performed according to standard protocols 37 using probes for Agtrl1,Cre, Eomes, Klhl6, Mesp1, Myl7, Nkx2.5, Rasgrp3, and Wnt2. LacZ staining was performed as described 37 . For histology, embryos were post-fixed in 4% PFA, dehydrated through an ethanol series, embedded in paraffin, sectioned at 8 μM and Eosincounterstained.
Definitive endoderm and cardiomyocyte differentiation assays
Wild-type (CCE), Eomes null (6A6) and Smad2 null (KT 15) feeder-depleted ES cells were cultured in DMEM (Invitrogen) with 15% FCS, 1% non-essential amino acids, 0.1 mM β-mercaptoethanol and 1000 U/ml recombinant LIF (Millipore). To induce DE differentiation, ES cells were cultured in serum-free ESGRO Complete clonal grade medium (Millipore) on 0.1% gelatin-coated dishes for a minimum of 2-3 passages before seeding at low density (18,000 cells/ml) in ESGRO Complete basal medium (Millipore) in bacteriological grade dishes, to promote embryoid body (EB) formation. 50 ng/ml Activin A (R&D systems) was added after 48hrs. For titration of ActivinA effects, the medium was changed after 72 hrs and new medium added with 5 or 50 ng/ml ActivinA. For cardiac differentiation, ES cells were re-suspended at 1 × 10 4 cells/ml in IMDM (Invitrogen) supplemented with 20% fetal calf serum, 1% non-essential amino acids, and 0.1 mM β-mercaptoethanol in hanging drops (10 μl) plated on the inside lids of bacteriological dishes. After 48hrs EBs were transferred in 10 ml medium to 10 cm bacteriological dishes. At day 4 EBs were plated on tissue culture dishes, allowed to adhere and scored at d7. EBs were plated on fibronectin-coated 15 μ-Slide 2×9well (Ibidi) and cultured for additional 96 hrs prior to imaging and immunostaining. The number and percentage of beating EBs was counted in three independent experiments. Live cell imaging was recorded on a Zeiss Observer Z.1 microscope equipped with an Axiocam MRm camera at frame rates of 10/s and 36/s.
P19Cl6 cell culture, differentiation and generation of EomesER expressing sub-clones
P19Cl6 EC cells were routinely cultured in α-MEM (Invitrogen) supplemented with 10% FCS. To induce differentiation, cells were seeded at 3.7×10 5 cells/6 cm dish in media containing 1% DMSO (Sigma). Cells were electroporated with linearised pCAGEomesER-IRESPuro vector 38 and selected in 1 μg/ml puromycin, to generate P19EoER sub-clones. Expression of the EomesER fusion protein was confirmed by Western blot analysis. For EomesER activation 1 μg/ml of 4-Hydroxytamoxifen (Sigma, H7904) was added to the culture media.
RNA isolation, One-step & quantitative RT-PCR analysis
RNA was isolated using the RNeasy Kit (Qiagen) according to the manufacturer's instructions, using on-column DNase treatment. cDNA was generated using the SuperScriptIII kit (Invitrogen) with oligo-dT primers. Q-RT-PCR was performed using the Quantitect SYBRGreen PCR kit and a Rotar-gene Q (Qiagen) and analysed using the ΔΔCt method, as described previously 39 . For one-step RT-PCR analysis, the One-step RT-PCR kit (Qiagen) was used with gene specific primers according to manufacturer's instructions. Primer sequences are provided in Supplementary Information Table S1 .
Chromatin Immunoprecipitation
Cells were cross-linked for 10 minutes at RT with 1% (v/v) formaldehyde and quenched with 125 mM glycine. Prepared chromatin was sonicated to 200-500 bp and immunoprecipitated with 15 μg of anti-Eomes (Abcam, ab23345), anti-PolII N-terminal (Santa Cruz, sc-899x) or normal rabbit IgG (Santa Cruz, sc-2027). Eluted DNA was recovered by phenol-chloroform extraction, precipitated with ethanol and resuspended in TE buffer. ChIP material was analysed using a Rotar-Gene Q (Qiagen) and SYBRGreen master mix (Qiagen). The amount of precipitated DNA was compared to the starting input material, as percentage of input. Each ChIP experiment was performed at least three times on separate biological samples. Q-PCR was performed in triplicate. ChIP primer sequences are provided in Supplementary Information Table S2 . 
Western blot analysis
Cell lysates were prepared using RIPA buffer and subjected to SDS-PAGE and transferred onto PVDF membranes. Membranes were blocked with 5% milk in TBS-T, incubated in primary antibodies overnight including rabbit anti-Eomes (Abcam, ab23345, 1:1000), rabbit anti-phospho-Smad2 (Cell Signaling, 3101, 1:1000) and mouse anti-γ-tubulin (Sigma, T6557, 1:3000). Secondary antibodies were donkey anti-rabbit-HRP (Amersham NA934V, 1:2000) and goat anti-mouse (Dako, P0447, 1:2000). Blots were developed by chemiluminescence using ECL plus (Amersham).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. Eomes and dose-dependent Nodal/Smad2/3 signalling levels control cardiac mesoderm and definitive endoderm specification during gastrulation. (a) Smad4 and Foxh1 are critical Nodal pathway components for transducing high levels of signalling 6, 12, 13 . Mesp1 is expressed normally in E6.5 and 7.5 Foxh1 null embryos and in embryos lacking Smad4 in the epiblast only (Smad4Δ). Mesp1 expression is also efficiently induced in Lhx1 mutant embryos, which display DE and midline mesoderm defects. However the failure of A-P axis rotation results in induction of Mesp1 throughout the 
